Two people can take the same dose of the same medicine and have very different results. One may improve, while the other gets ...
Long a frontrunner in donor-derived cell therapy research, the French biotech cited a shifting landscape in changing course ...
It turns out my status as an alcohol lightweight is likely dictated by my genes. Scientists have long known that excessive ...
A multi-ancestry polygenic risk score improved HCM risk prediction in a diverse U.S. population of more than 258,000 people.
Cellectis has announced that its board of directors have approved a strategic transformation to become an in vivo gene ...
Realizing the potential of cell and gene therapies will require organizations to rethink how they finance care and build the ...
By Dennis Thompson HealthDay ReporterTHURSDAY, Sept. 3, 2026 (HealthDay News) — Genetics help shape your personality, and ...
Editas Medicine (NASDAQ:EDIT) outlined its strategy as an in vivo gene-editing company and said it remains on track to dose ...
A new meta-analysis pooled data from more than one million people to look at the crossover between DNA and the "Big Five" ...
Strengthened laws should help to ensure future deaths are quickly disclosed to the public, but China’s reputation for such ...
Long a frontrunner in donor-derived cell therapy research, the French biotech cited a shifting landscape in changing course ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results